Duncan H. Mak
- Molecular Biology top 5%
- Hematology top 1%
- Oncology top 10%
- Complementary and alternative medicine top 0.5%
- Genetics top 5%
- Co-authors
- Michael AndreeffBing Z. CarterWendy SchoberMichel K.T. PoonPo Yee MakKam Ming KoMarina KonoplevaJörge E. Cortes
- Topics
- Acute Myeloid Leukemia Research (24 papers)Cell death mechanisms and regulation (22 papers)Chronic Myeloid Leukemia Treatments (15 papers)
- Partner nations
- United StatesHong KongChina
In The Last Decade
Duncan H. Mak
84 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 1.6k
- Hematology 698
- Oncology 428
- Complementary and alternative medicine 399
- Genetics 280
Countries citing papers authored by Duncan H. Mak
This map shows the geographic impact of Duncan H. Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan H. Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan H. Mak more than expected).
Fields of papers citing papers by Duncan H. Mak
This network shows the impact of papers produced by Duncan H. Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan H. Mak. The network helps show where Duncan H. Mak may publish in the future.
Co-authorship network of co-authors of Duncan H. Mak
This figure shows the co-authorship network connecting the top 25 collaborators of Duncan H. Mak. A scholar is included among the top collaborators of Duncan H. Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan H. Mak. Duncan H. Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 49 | |
| 4 | 9 | |
| 5 | 22 | |
| 6 | 67 | |
| 7 | 31 | |
| 8 | 73 | |
| 9 | 61 | |
| 10 | 17 | |
| 11 | 22 | |
| 12 | 41 | |
| 13 | 26 | |
| 14 | 11 | |
| 15 | 44 | |
| 16 | 26 | |
| 17 | 103 | |
| 18 | 6 | |
| 19 | 18 | |
| 20 | 34 |
About Duncan H. Mak
Duncan H. Mak is a scholar working on Hematology, Complementary and alternative medicine and Genetics, having authored 88 papers that have together received 2.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Cell death mechanisms and regulation (22 papers) and Chronic Myeloid Leukemia Treatments (15 papers). The work is most often cited by research in Hematology (698 citations), Complementary and alternative medicine (399 citations) and Genetics (280 citations). Duncan H. Mak has collaborated with scholars based in United States, Hong Kong and China. Frequent co-authors include Michael Andreeff, Bing Z. Carter, Wendy Schober, Michel K.T. Poon, Po Yee Mak, Kam Ming Ko, Marina Konopleva, Jörge E. Cortes, Teresa McQueen and Hagop M. Kantarjian. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.